Viela Bio enrolling kidney transplant recipients for phase IIa trial of VIB-4920 and belatacept Oct. 15, 2019
Collaborative Medicinal Development enrolls first patient in new study of CuATSM for ALS Oct. 15, 2019
Primary endpoint met in registrational MOXIe trial of omaveloxolone for Friedreich's ataxia Oct. 15, 2019
Immunotherapy frontiers: 'Strength in numbers', 'it only takes one' both true for neoantigens Oct. 15, 2019
Intra-Cellular Therapies discovers 5-HT2A antagonists/mu-opioid receptor partial agonists Oct. 15, 2019
RSS